Acute Myeloid Leukemia News and Research

RSS
Acute Myeloid Leukemia (AML) is a rapidly progressing cancer of the blood characterized by the uncontrolled proliferation of immature blast cells in the bone marrow. The Leukemia and Lymphoma Society estimates that over 13,000 new cases of AML were diagnosed and approximately 9,000 deaths from AML occurred in the U.S. during 2007. AML is generally a disease of older adults, and the median age of a patient diagnosed with AML is about 67 years. A majority of elderly patients are not considered candidates for standard induction therapy or decline therapy, resulting in an acute need for new treatment options.
Thiarabine shows promise for rheumatoid arthritis

Thiarabine shows promise for rheumatoid arthritis

Potential new target for acute myeloid leukemia

Potential new target for acute myeloid leukemia

“Misreading” of histone code linked to human cancer

“Misreading” of histone code linked to human cancer

Anti-viral ribavirin may prove effective in treatment of many cancers

Anti-viral ribavirin may prove effective in treatment of many cancers

Vion Pharmaceuticals' NDA for Onrigin accepted for FDA review

Vion Pharmaceuticals' NDA for Onrigin accepted for FDA review

Molecule called miR-29b could be a potent treatment for acute myeloid leukemia

Molecule called miR-29b could be a potent treatment for acute myeloid leukemia

Researchers develop mouse models of leukemia that predict response to chemotherapy

Researchers develop mouse models of leukemia that predict response to chemotherapy

Molecular machine turns packaged messenger RNA into a linear transcript

Molecular machine turns packaged messenger RNA into a linear transcript

Quit smoking one week at a time

Quit smoking one week at a time

Biopure submits IND for trial in patients with acute myeloid leukemia

Biopure submits IND for trial in patients with acute myeloid leukemia

VIDAZA (azacitidine) study reports survival benefit in higher-risk MDS extends to AML patients

VIDAZA (azacitidine) study reports survival benefit in higher-risk MDS extends to AML patients

Dacogen data presented on trial in seniors with acute myeloid leukemia

Dacogen data presented on trial in seniors with acute myeloid leukemia

Trial shows safety of pre-transplant expansion of umbilical cord blood stem cells

Trial shows safety of pre-transplant expansion of umbilical cord blood stem cells

Effects of stem cell source and patient age on stem cell transplantation outcomes

Effects of stem cell source and patient age on stem cell transplantation outcomes

Age has no impact on survival after bone marrow transplant

Age has no impact on survival after bone marrow transplant

Trial shows Elitek significantly reduces plasma uric acid levels versus Allopurinol in adults with hematologic cancers at risk for tumor Lysis syndrome

Trial shows Elitek significantly reduces plasma uric acid levels versus Allopurinol in adults with hematologic cancers at risk for tumor Lysis syndrome

Celator Pharmaceuticals enrols first patient in phase 2 study of CPX-351 in acute myeloid leukemia

Celator Pharmaceuticals enrols first patient in phase 2 study of CPX-351 in acute myeloid leukemia

Sunesis Pharmaceuticals presents data of Voreloxin in patients with acute myeloid leukemia and ovarian cancer

Sunesis Pharmaceuticals presents data of Voreloxin in patients with acute myeloid leukemia and ovarian cancer

Potential therapeutic target for acute leukemia types

Potential therapeutic target for acute leukemia types

Lorus initiates development program exploring novel route of administration for LOR-2040

Lorus initiates development program exploring novel route of administration for LOR-2040